Is Roche NimbleGen optimizing their Sequence Capture technology with any of the next-generation sequencing platforms?
Yes, we are currently developing 385K Sequence Capture products that use a protocol optimized for the 454 GS FLX instrument using Titanium Series Kits. This provides a seamless transition from capture into sequencing since no library preparation needs to be performed after array capture. Captured fragments are ready to go into the emPCR step.
Yes, we are currently developing 385K Sequence Capture products that use a protocol optimized for the 454 GS FLX Instrument using GS FLX Titanium Series Kits. This provides a seamless transition from capture into sequencing since no library preparation needs to be performed after array capture. Captured fragments are ready to go into the emPCR Amplification step.
Related Questions
- Is Roche NimbleGen optimizing their Sequence Capture technology with any of the next-generation sequencing platforms?
- Are there any publications demonstrating the reproducibility and robustness of NimbleGen Sequence Capture technology?
- What level of training does Roche NimbleGen provide for Sequence Capture Array delivery?
